MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview with K. Craig Kent, MD
The outgoing President of the SVS discusses the challenges facing vascular surgery, the role of the individual surgeon, and the bright future he sees for the specialty.
By K. Craig Kent, MD
Making Sense of Apples-to-Oranges Comparisons
K. Craig Kent, MD, describes the advantages and disadvantages of each of the available datasets on endovascular repair in high-risk patients, including what has been learned from the extensive Medicare database.
Screening for Abdominal Aortic Aneurysms
An update on the progress made in identifying patients with AAAs and the work that must still be done.
By Robert M. Zwolak, MD, and K. Craig Kent, MD
Malignancy-Related SVC Syndrome
Endovascular treatment of this patient population has been shown to be effective.
By Robert L. Hynecek, MD; Brian G. DeRubertis, MD; Rabih A. Chaer, MD;K. Craig Kent, MD; and Peter L. Faries, MD
SVS Publishes Evaluation of AAA Risk Using New Predictive Scoring System
August 19, 2010—The Society for Vascular Surgery (SVS) announced that results of an evaluation of the data on 3.1 million patients who were at risk for abdominal aortic aneurysms (AAAs) will be published by K. Craig Kent, MD, et al in the September issue of the Journal of Vascular Surgery and are currently available online.
Evaluating EVAR
By Barry T. Katzen, MD, Chief Medical Editor
Issues in Comparative High-Risk Datasets
Roy K. Greenberg, MD, explains the Cleveland Clinic's experiences with high-risk aneurysm patients, the limitations of current comparative analyses, and the search for predictors of mortality.
By Roy K. Greenberg, MD
DREAM's 6-Year Survival Rates for EVAR Equal to Open Repair
May 20, 2010—Long-term findings from the DREAM (Dutch Randomized Endovascular Aneurysm Management) trial comparing open surgical repair (OAR) and endovascular repair (EVAR) of abdominal aortic aneurysms (AAAs) have been published by Jorg L. De Bruin, MD, et al in the New England Journal of Medicine (2010:362;1881–1889).
DREAM's 6-Year Survival Rates for EVAR Equal to OAR
Access Strategy and Improvement
Pressure-Sensing Guidewire Analysis in RAS
Adapting this coronary-based technology to optimize “functional” renal artery revascularization could have significant clinical implications.
By David E. Allie, MD; Chris J. Hebert, RT, RCIS; and Craig M. Walker, MD
12-Month EXCITE ISR Data Presented at New Cardiovascular Horizons, Showing Favorable Results for Laser in In-Stent Restenosis
May 27, 2015—Twelve-month data from the Excimer Laser Randomized Controlled Study for Treatment of Femoropopliteal In-Stent Restenosis (EXCITE ISR) were presented at the New Cardiovascular Horizons (NCVH) meeting in New Orleans, Louisiana.